Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Bioinformatics Tool to Identify Chromosomal Alterations in Tumor Cells Can Improve Cancer Diagnosis

By LabMedica International staff writers
Posted on 25 Mar 2024

Chromosomal instability is a common characteristic in solid tumors, playing a crucial role in the start, progression, and spread of cancer. More...

This condition arises from alterations in the chromosome number and structure during cell division, leading to DNA changes and impacts on cellular functions. Furthermore, chromosomal instability contributes to tumor development and progression, increases tumor diversity, and fosters resistance to cancer treatments. Now, a new bioinformatics tool that can identify these chromosomal alterations characteristic of cancer cells could improve diagnosis and help design personalized treatment plans.

This new detection system, known as QATS (QuAntification of Toroidal nuclei in biological imageS), has been designed by a research team from the University of Barcelona (Barcelona, Spain) and IRB Barcelona (Barcelona, Spain). This computational biological imaging processing tool can improve tumor research and classification by automatically identifying and quantifying the phenotypes associated with chromosomal instability in the nuclei of cancer cells. QATS focuses on detecting and quantifying toroidal nuclei, which are new biomarkers of chromosomal instability, in biological images. Unlike normal nuclei, toroidal nuclei are phenotypically different as they have a ring-like shape with a void containing cytosolic material. Recognized recently as critical biomarkers for chromosomal instability, toroidal nuclei offer a new avenue for understanding and combating cancer.

Until now, the assessment of chromosomal instability in cancer cells has been primarily based on quantifying micronuclei, which are irregular structures derived from the cell nucleus that may contain chromosomes or chromosomal fragments. By introducing the assessment of toroidal nuclei into both research and clinical settings, there is significant potential for improving tumor classification and developing treatments tailored to individual patients. The QATS system has already proven effective in preclinical studies involving cancer cell lines by demonstrating its capability to identify and quantify toroidal nuclei accurately.

“In the future, the application of QATS in more complex biological scenarios — human tissue samples from patient biopsies — will represent a breakthrough for the scientific and medical communities to improve cancer diagnosis and patient treatment”, concluded the researchers.

Related Links:
University of Barcelona
IRB Barcelona


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.